OpenAI moves to trademark its ‘reasoning’ models

Date:

Share post:


OpenAI has filed a trademark application for its latest AI model, o1, as the firm moves to shield its IP.

On Tuesday, OpenAI submitted paperwork to the U.S. Patent and Trademark Office (USPTO) to register the trademark “OpenAI o1.” Interestingly, the documents reveal that OpenAI filed for a foreign trademark application in Jamaica in May, months before o1 was announced.

The USPTO hasn’t granted OpenAI the trademark yet. According to the office’s online database, the application is currently awaiting assignment to an examining attorney.

OpenAI has said that it intends for o1, its first “reasoning” model, to expand into a series of models trained to perform complex tasks. Unlike most models, reasoning models effectively fact-check themselves by spending more time considering a question or query — helping them avoid some common AI pitfalls.

OpenAI, which has filed for around 30 trademark registrations to date, including for “ChatGPT,” “Sora,” “GPT-4o,” and “DALL-E,” famously failed to trademark “GPT” in February after the USPTO ruled that the term was too generic. GPT, which stands for “Generative Pre-trained Transformer,” was in use in other contexts and by other companies when OpenAI submitted its request, the office noted.

OpenAI hasn’t aggressively asserted its trademarks yet — save for one. For several months, the startup has been fighting technologist and entrepreneur Guy Ravine for the right to use “Open AI,” which Ravine claims he pitched as a part of an “open source” AI vision around 2015 — OpenAI’s founding year.

A federal circuit court upheld a preliminary injunction in OpenAI’s favor early this fall, ruling that OpenAI was likely to prevail against Ravine.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Neom is reportedly turning into a financial disaster, except for McKinsey & Co.

A new WSJ report suggests that Saudi Arabia’s now eight-year-old Neom project — a futuristic, carbon-neutral, 105-mile-long...

Manus probably isn’t China’s second ‘DeepSeek moment’

Manus, an “agentic” AI platform that launched in preview last week, is generating more hype than a...

Japan’s service robot market projected to triple in five years

Faced with an aging population and labor shortages, Japanese businesses are increasingly relying on service robots to...

Colossal CEO Ben Lamm says humanity has a ‘moral obligation’ to pursue de-extinction tech

The CEO of Colossal, a startup that aims to use genetic editing techniques to bring back extinct...

Tammy Nam joins AI-powered ad startup Creatopy as CEO

Creatopy, a startup that uses AI to automate the creation of digital ads, has brought on a...

Apple’s smart home hub reportedly delayed by Siri challenges

Apple announced this week that the “more personalized” version of Siri that it promised last year has...

Musk may still have a chance to thwart OpenAI’s for-profit conversion

Elon Musk lost the latest battle in his lawsuit against OpenAI this week, but a federal judge...

How to stop doomscrolling

The world is bad sometimes, but it feels even worse if you can’t stop staring into the...